TrialHaematologica2011

Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission.

Marc Buyse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.